{"SPADE_UN_16181": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16181", "Peptide Name": "N22b", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KILGVSKKIMRRISKDILTGKK", "Sequence Length": 22, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HeLa  (Not active up to 100μg/ml)", "Hemolytic Activity": "Human erythrocytes:<5% Hemolysis=100 µg/ml", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C112H210N34O28S", "Mass": 2513.14, "PI": 11.26, "Net Charge": 7, "Hydrophobicity": -0.33, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens", "Pubmed ID": "17389605", "Reference": "J Biol Chem. 2007 May 18;282(20)14719-28.", "Author": "Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17389605"}], "Frequent Amino Acids": "KIG", "Absent Amino Acids": "ACEFHNOPQUWY", "Basic Residues": 8, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 12, "Positive Residues": 8, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15314", "Similarity": 1.0, "Sequence": "KILRGVSKKIMRTFLRRISKDILTGKK"}, {"SPADE_ID": "SPADE_UN_16180", "Similarity": 1.0, "Sequence": "KILRGVSKKIMRRISKDILTGKK"}, {"SPADE_ID": "SPADE_UN_16183", "Similarity": 1.0, "Sequence": "KILRGVSKKIMRRILTGKK"}]}}}